Sleep
Is there anything measured for sleep?
A short section, honestly. People take a lot of supplements for sleep, but few have been studied. This page shows how little of the noise has been tested in people.
16 compounds studied for this · 5 with a completed trial of a hundred people or more · 2 with no study in people at all
What has actually been measured here
This page lists the compounds studied for sleep. These pages work the other way round. They take one goal at a time and list every compound by how many people it was measured in, most first. Each shows what the study found, and the trials that found nothing are counted.
Strong and Moderate 5
At least one finished trial that gave the compound to a hundred people or more. That tells you how much has been measured. It does not tell you whether it will work for you. The math sits under every band.
Epitalon
Moderate. At least one finished study in people, and at least 100 people who took it. 5 completed trials, 266 people given it.6 reported6 citedA lab-made peptide based on a pineal gland extract. It has more human data than its reputation suggests, including 266 o...
PeptideAnti-agingOveporexton
Moderate. At least one finished study in people, and at least 100 people who took it. 6 completed trials, 441 people given it.6 citedA pill for narcolepsy type 1 that works on the brain's orexin wake system. It is not a peptide. The FDA approved it for...
Small moleculeNootropic & CNSSermorelin with ipamorelin
Moderate. At least one finished study in people, and at least 100 people who took it. 1 completed trial, 117 people given it.8 reported3 citedThis is the blend most likely to come from a compounding pharmacy with a prescriber's name on it. It is usually a nightl...
BlendGrowth HormoneMK-677 with ipamorelin
Moderate. At least one finished study in people, and at least 100 people who took it. 2 completed trials, 182 people given it.7 reported2 citedNot one vial but one plan: a daily pill alongside a shot. Both press the same switch, so this is one way of working give...
BlendGrowth HormoneSelank
Moderate. At least one finished study in people, and at least 100 people who took it. 3 completed trials, 192 people given it.8 reported3 citedA lab-made peptide from Russia, used for anxiety. It is said to calm people without making them sleepy.
PeptideNootropic & CNSLimited and Preliminary 9
Someone has been given it and a result was published, but in fewer than a hundred people. Or the studies in people only watched and never gave anybody anything. The math on each card says exactly how thin.
DSIP
Limited. People have taken it in a published study, but fewer than 100 of them. 6 completed trials, 7 people given it.8 reported6 citedA natural peptide studied for sleep, stress and pain. The human evidence is thin and mixed.
PeptideNootropic & CNSMagnesium
Limited. People have taken it in a published study, but fewer than 100 of them. 1 completed trial, 46 people given it.4 reported1 citedIt lowers blood pressure by a real but small amount, about 2 points. The sleep evidence is three small studies in 151 pe...
SupplementLongevityMK-677
Limited. People have taken it in a published study, but fewer than 100 of them. 2 completed trials, 65 people given it.11 reported3 citedA daily pill that raises growth hormone and IGF-1. It is not a peptide. It was tested in people for years but was never...
Small moleculeGrowth HormoneDSIP with selank and epitalon
Limited. People have taken it in a published study, but fewer than 100 of them. 1 completed trial, 62 people given it.6 reported3 citedA sleep and body clock blend, usually 2 mg DSIP, 2 mg epitalon and 0.5 mg selank. So the two bigger ingredients are each...
BlendNootropic & CNSCJC-1295 with GHRP-2
Limited. People have taken it in a published study, but fewer than 100 of them. 2 completed trials, none stating how many people.8 reported3 citedA 10 mg vial split evenly between two kinds of growth hormone booster. One copies GHRH, the brain's own growth hormone s...
BlendGrowth HormoneEndoluten
Preliminary. Studied in people, but no published study has had people take it. 3 human studies where nobody was given it.8 reported3 citedA pineal gland capsule sold on the long-life claims of two other products. A PubMed search for Endoluten finds zero pape...
PeptideAnti-agingAshwagandha
Limited. People have taken it in a published study, but fewer than 100 of them. 1 completed trial, none stating how many people.2 reported2 citedAn optional part of Aaron's stack, for stress and sleep. There are trials of root extracts tested against a dummy pill....
SupplementLongevityOrexin-A
Limited. People have taken it in a published study, but fewer than 100 of them. 1 completed trial, 14 people given it.2 reported1 citedOrexin-A is the brain chemical that keeps you awake. It is sold as a nose spray for alertness, after a monkey study foun...
PeptideNootropic & CNSMonlunabant
Limited. People have taken it in a published study, but fewer than 100 of them. 1 completed trial, none stating how many people.2 reported2 citedNovo Nordisk's CB1 blocker pill, built to act mostly outside the brain. People lost 7.1 kg in 16 weeks, but anxiety, irr...
Small moleculeMetabolicAnimal or lab only, and nothing measured 2
Studied in animals or in cells in a dish, or studied in people for something else entirely. Listed, not hidden, because knowing a thing has not been tested in a person is the useful part.
Melatonin
None. No study cited on this page yet. no study cited on this page yet.1 reportednone citedA 2013 review that pooled studies found melatonin had a small effect on sleep problems. No blood test sets your dose. Wh...
SupplementLongevitySR9009
Animal or lab only. Only animal or lab studies on this page. No study in people yet. 1 animal study, 1 lab study, no human study.4 reportednone citedSR9009 is sold as exercise in a pill. It targets REV-ERB, part of the body clock. No human study has ever been published...
Small moleculeMetabolicReading on this goal
Peptides for Longevity: What the Evidence Actually Shows in 2026
A full review of every peptide and related compound sold for aging: GLP-1 drugs, rapamycin, the growth hormone peptides, epitalon, thymalin, klotho, humanin, senolytics, SS-31, GHK-Cu, MOTS-c and FOXO4-DRI. What happened in people, what happened in animals and the legal status of each, in one table. Plain English.
Peptides for Sleep: DSIP, Epitalon and Pinealon Against the Evidence
What the DSIP sleep studies from 1981 to 1992 actually found, why an FDA panel voted against DSIP (emideltide) and for Epitalon in July 2026, what one Russian lab's melatonin data can and cannot show, how growth hormone signals change deep sleep, and how it all compares with approved sleep drugs. Plain English.
Peptide Side Effects by Class: What Is Documented, What Is Anecdotal
A group-by-group table that separates side effects counted in studies and on FDA labels (GLP-1 drugs, bremelanotide, MK-677, elamipretide) from the stories that fill forums about BPC-157, TB-500, copper peptides and brain peptides. Plain English.
FDA Peptide Status in 2026: The Category 2 Removals, the July Votes, and What Actually Changed
A dated tracker of where BPC-157, TB-500, KPV, MOTS-c, Epitalon, Semax and DSIP stand with the FDA after the April 2026 list change and the July 23 to 24 advisory panel votes. Plain English, with a link to every source.
What the number counts, exactly
The number on each card is how many sources on that compound’s page are studies in people. It is counted the same simple way for all 453 compounds. You can check any of it by opening the profile and reading the list of sources. That is the whole point of showing a number at all.
It counts what we cite. It does not claim how much research exists. A compound with three studies in people here may have thirty in print, and the honest thing to say is that we have read and listed three. It is also not a quality score. Three small, loose studies count the same as three careful ones. So the groups tell you how much was measured in people, and the profile page tells you how well.